Philip L. Johnson - Feb 27, 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP & Chief Financial Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Philip L. Johnson
Stock symbol
JAZZ
Transactions as of
Feb 27, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 07:24 PM
Previous filing
Mar 5, 2024
Next filing
Mar 7, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +15.4K +54.83% $0.00 43.5K Feb 27, 2025 Direct F1, F2
transaction JAZZ Ordinary Shares Award $0 +7.7K +17.71% $0.00 51.2K Feb 27, 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F2 The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024.
F3 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.